Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1048 of 1048 entries
View as:

A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04394598 Org: User:
Start: 03/01/20 End: 12/01/22 Due: 12/01/23

Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC

Phase: N/A Priority: Normal
NCT ID: NCT05970705 Org: User:
Start: 07/01/23 End: 07/04/26 Due: 07/04/27

Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02777437 Org: User:
Start: 10/31/16 End: 10/31/21 Due: 10/31/22

The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine

Phase: N/A Priority: Normal
NCT ID: NCT01677325 Org: User:
Start: 01/31/07 End: 01/31/08 Due: 01/31/09

Feasibility in Identification of Breast Cancer Candidates for Elimination of Axillary Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05663021 Org: User:
Start: 07/01/17 End: 02/28/22 Due: 02/28/23

Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06462053 Org: User:
Start: 04/01/24 End: 03/01/27 Due: 03/01/28

Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06349252 Org: User:
Start: 01/01/21 End: 01/01/25 Due: 01/01/26

Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05673577 Org: User:
Start: 03/22/23 End: 08/31/25 Due: 08/31/26

Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05076695 Org: User:
Start: 10/15/21 End: 10/15/24 Due: 10/15/25

Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC

Phase: N/A Priority: Normal
NCT ID: NCT05229003 Org: User:
Start: 03/09/22 End: 12/31/25 Due: 12/31/26

The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?

Phase: N/A Priority: Normal
NCT ID: NCT01696682 Org: User:
Start: 09/30/12 End: 12/31/14 Due: 12/31/15

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04687631 Org: User:
Start: 01/14/21 End: 09/30/27 Due: 09/30/28

Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04518280 Org: User:
Start: 05/01/21 End: 01/01/25 Due: 01/01/26

CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04917289 Org: User:
Start: 06/01/21 End: 12/01/25 Due: 12/01/26

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05468138 Org: User:
Start: 08/25/22 End: 12/31/25 Due: 12/31/26

Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen

Phase: N/A Priority: Normal
NCT ID: NCT04101929 Org: User:
Start: 10/01/19 End: 12/31/21 Due: 12/31/22

Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06911528 Org: User:
Start: 01/30/24 End: 12/31/25 Due: 12/31/26

Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Band Ligation (EMBL) for Early Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02952794 Org: User:
Start: 01/31/17 End: 12/31/20 Due: 12/31/21

Ivocizumab in the Treatment of Multiple Advanced Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06683846 Org: User:
Start: 11/20/24 End: 11/30/27 Due: 11/30/28

Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06718946 Org: User:
Start: 12/10/24 End: 12/31/27 Due: 12/31/28

Peri-operative Foot CT Perfusion in CLI Patients

Phase: N/A Priority: Normal
NCT ID: NCT05575778 Org: User:
Start: 10/01/22 End: 06/30/25 Due: 06/30/26

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Phase: N/A Priority: Normal
NCT ID: NCT04593485 Org: User:
Start: 10/28/20 End: 12/31/23 Due: 12/31/24

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06521866 Org: User:
Start: 03/01/25 End: 08/01/27 Due: 08/01/28